For decades, 316L stainless steel has been the material of choice for pharmaceutical manufacturing equipment. Its corrosion resistance, cleanability, weldability, and ability to maintain hygienic surfaces make it the industry standard for everything from piping systems to storage vessels. In many pharmaceutical applications, 316L remains the right choice.
However, as pharmaceutical manufacturing continues to evolve, facilities are often adopting more efficient production methods that rely on increasingly aggressive cleaning chemistries and operating conditions where standard stainless steel may not provide the desired level of corrosion resistance or long-term reliability.
As a result, more pharmaceutical manufacturers are evaluating alternatives, including nickel alloys, for critical process areas.
Why Pharmaceutical Manufacturing Is So Demanding
Pharmaceutical production is about far more than simply mixing ingredients. Every process must meet strict cleanliness, sterility, and product purity requirements. Even microscopic contamination can result in an entire batch being discarded, making equipment reliability critical. The industry also operates in environments that are surprisingly corrosive, often involving:
- Strong acids and cleaning chemicals
- High-chloride process streams
- Salt-rich biological buffers
- Aggressive sanitization cycles
- Repeated exposure to high-temperature steam
- Continuous cleaning and sterilization procedures
Where Corrosion Becomes a Concern
While 316L stainless steel performs well throughout much of a pharmaceutical facility, certain process conditions can create more aggressive corrosion challenges. Modern drug manufacturing often combines harsh cleaning chemicals, high-chloride solutions, acidic process streams, and repeated sterilization cycles all within the same production environment.
Clean-in-Place (CIP) systems routinely circulate heated caustic solutions, acids, and other cleaning agents to remove residue between production runs. Following cleaning, Sterilize-in-Place (SIP) systems subject equipment to high-pressure, high-temperature steam to eliminate remaining microorganisms. Over time, the combination of aggressive chemistry and repeated thermal cycling can place significant demands on process equipment
Many pharmaceutical and biopharmaceutical processes also rely on chloride-containing buffers, saline solutions, and acidic media. These environments can increase the risk of localized attack such as pitting and crevice corrosion, particularly in critical product-contact areas where equipment integrity and product purity are paramount.
In these applications, engineers may look beyond conventional stainless steels and evaluate nickel alloys that offer enhanced resistance to corrosive process conditions.
Enter the Nickel Alloys
When greater corrosion resistance is required, engineers often evaluate nickel-chromium-molybdenum alloys that are designed to withstand aggressive pharmaceutical process environments. Common choices include Alloy C-276, Alloy 22, Alloy 625, and Alloy 600, each offering a combination of resistance to chlorides, acids, high-temperature steam, and other corrosive conditions.
Alloy C-276
Often specified for reactors, mixing tanks, agitators, and other process equipment exposed to aggressive chemicals. Alloy C-276 is known for its excellent resistance to localized corrosion, including pitting and crevice attack.
Alloy 22
A versatile Ni-Cr-Mo alloy that offers exceptional corrosion resistance across a wide range of oxidizing and reducing environments. Alloy 22 is frequently selected for critical product-contact components and demanding biopharmaceutical applications.
It’s Often Specific Components, Not Entire Vessels
Specifying a nickel alloy doesn’t necessarily mean replacing an entire vessel. In many pharmaceutical systems, 316L remains the primary construction material while higher-alloy materials are used only in the areas exposed to the most severe operating conditions. Components such as spargers, spray balls, impeller blades, agitator shafts, mechanical seals, and other critical product-contact surfaces may be upgraded to improve corrosion resistance and long-term reliability.
Choosing the Right Material
For most pharmaceutical applications, 316L remains an excellent and cost-effective choice. However, when aggressive cleaning chemicals, chlorides, acids, sterilization cycles, or critical product-contact requirements are involved, nickel alloys can provide an additional margin of protection against corrosion, contamination, and unexpected downtime.
Understanding where these environments exist is the first step toward selecting the right material for long-term reliability. In our next article, we’ll take a closer look at Alloy 22 and why it has become a preferred solution for some of the pharmaceutical industry’s most demanding applications, as well as many other highly corrosive service environments.
If you’re evaluating materials for a pharmaceutical application, Corrosion Materials can help. Our team can provide information on how nickel alloys perform in a variety of chemical and process environments, helping you better understand the material options available for your application. Contact us to discuss your operating conditions, material specifications, or sourcing requirements.